{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:53:46Z","timestamp":1794002026120,"version":"4.8.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009096","name":"FU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009096","name":"FU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejca.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T11:20:41Z","timestamp":1562412041000},"page":"10-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":503,"special_numbering":"C","title":["Diagnosis and treatment of basal cell carcinoma: European consensus\u2013based interdisciplinary guidelines"],"prefix":"10.1016","volume":"118","author":[{"given":"Ketty","family":"Peris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-9826","authenticated-orcid":false,"given":"Lars","family":"Bastholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Basset","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique del","family":"Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Haedersdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-1685","authenticated-orcid":false,"given":"Mark R.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin A.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-8707","authenticated-orcid":false,"given":"Eduardo","family":"Nagore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Stratigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf-Markus","family":"Szeimies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Trakatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-4955","authenticated-orcid":false,"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-4062","authenticated-orcid":false,"given":"Jean Jacques","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2019.06.003_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1684\/ejd.2014.2271","article-title":"Update of the European guidelines for basal cell carcinoma management","volume":"24","author":"Trakatelli","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2019.06.003_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1610-0379.2012.8018_3.x","article-title":"Brief S2k guidelines--Basal cell carcinoma of the skin","volume":"11","author":"Hauschild","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2019.06.003_bib3","first-page":"394","article-title":"Management of basal cell carcinoma in adults Clinical practice guidelines","volume":"16","author":"Dandurand","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.2008.08666.x","article-title":"Guidelines for the management of basal cell carcinoma","volume":"159","author":"Telfer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccr.2010.11.007","article-title":"Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+\/-) mice","volume":"19","author":"Wang","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2019.06.003_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.stem.2015.02.006","article-title":"Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches","volume":"16","author":"Peterson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejca.2019.06.003_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ncb2031","article-title":"Identification of the cell lineage at the origin of basal cell carcinoma","volume":"12","author":"Youssef","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ejca.2019.06.003_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","article-title":"Smoothened variants explain the majority of drug resistance in basal cell carcinoma","volume":"27","author":"Atwood","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2019.06.003_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2019.06.003_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112485","article-title":"Understanding the molecular genetics of basal cell carcinoma","volume":"18","author":"Pellegrini","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2019.06.003_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","article-title":"Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma","volume":"326","author":"Yauch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejca.2019.06.003_bib12","first-page":"1159","article-title":"Xeroderma pigmentosum - facts and perspectives","volume":"38","author":"Lehmann","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2019.06.003_bib13","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nm.4368","article-title":"Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas","volume":"23","author":"Bal","year":"2017","journal-title":"Nature Med"},{"key":"10.1016\/j.ejca.2019.06.003_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1751-1097.2010.00735.x","article-title":"Basal cell carcinoma: what's new under the sun","volume":"86","author":"Dessinioti","year":"2010","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.ejca.2019.06.003_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/jid.2008.234","article-title":"Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population","volume":"129","author":"Richmond-Sinclair","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5694\/j.1326-5377.2006.tb00086.x","article-title":"Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985","volume":"184","author":"Staples","year":"2006","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejca.2019.06.003_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2340\/00015555-2282","article-title":"Basal cell carcinoma is as common as the sum of all other cancers: implications for treatment capacity","volume":"96","author":"Holm","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.ejca.2019.06.003_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ejca.2019.06.003_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2133.1997.19482048.x","article-title":"An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow","volume":"137","author":"Lucke","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1365-2133.2007.07892.x","article-title":"Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003","volume":"156","author":"Brewster","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/jid.2012.431","article-title":"Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study","volume":"133","author":"Flohil","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10227-002-0135-0","article-title":"Epidemiology of skin tumors: data from the cutaneous cancer registry in Trentino, Italy","volume":"7","author":"Boi","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib23","first-page":"788","article-title":"Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010","volume":"13","author":"Rudolph","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2019.06.003_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjd.14352","article-title":"Survival with nonmelanoma skin cancer in Germany","volume":"174","author":"Eisemann","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"16","author":"Migden","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2016.06.020","article-title":"Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: a retrospective cohort study","volume":"75","author":"Goldenberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00403-013-1357-2","article-title":"Age distribution of patients with advanced non-melanoma skin cancer in the United States","volume":"305","author":"Dacosta Byfield","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ejca.2019.06.003_bib28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0190-9622(91)70108-E","article-title":"Metastatic basal cell carcinoma: report of twelve cases with a review of the literature","volume":"24","author":"Lo","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Kim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ejca.2013.12.013","article-title":"Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease","volume":"50","author":"McCusker","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.06.003_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/jamadermatol.2015.1188","article-title":"Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998-2012","volume":"151","author":"Asgari","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.0022-202X.2004.23306.x","article-title":"Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973","volume":"123","author":"de Vries","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.294.6.681","article-title":"Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years","volume":"294","author":"Christenson","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2019.06.003_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.07021.x","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/bjd.14153","article-title":"Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study","volume":"174","author":"Krynitz","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib36","article-title":"The diagnostic accuracy of dermoscopy for basal cell carcinoma: a systematic review and meta-analysis","author":"Reiter","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/bjd.12749","article-title":"Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma","volume":"170","author":"Apalla","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2013.10.003","article-title":"Accuracy of dermatoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma","volume":"70","author":"Lallas","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.ejca.2019.06.003_bib39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2340\/00015555-2113","article-title":"Subtyping basal cell carcinoma by clinical diagnosis versus punch biopsy","volume":"95","author":"Roozeboom","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaad.2015.12.038","article-title":"Standardization of terminology in dermoscopy\/dermatoscopy: results of the third consensus conference of the International Society of Dermoscopy","volume":"74","author":"Kittler","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaad.2009.05.035","article-title":"Dermoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis","volume":"62","author":"Altamura","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib42","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/jdv.12980","article-title":"Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location","volume":"29","author":"Suppa","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ced.13055","article-title":"Diagnostic accuracy of reflectance confocal microscopy using VivaScope for detecting and monitoring skin lesions: a systematic review","volume":"42","author":"Edwards","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib44","first-page":"CD013189","article-title":"Cochrane skin cancer diagnostic test accuracy group. Optical coherence tomography for diagnosing skin cancer in adults","volume":"12","author":"Ferrante di Ruffano","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2019.06.003_bib45","series-title":"WHO classification of skin tumors","year":"2018"},{"key":"10.1016\/j.ejca.2019.06.003_bib46","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jid.2016.02.012","article-title":"Research techniques made simple: noninvasive imaging Technologies for the Delineation of basal cell carcinomas","volume":"136","author":"Que","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/bjd.14244","article-title":"A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinoma","volume":"174","author":"Venturini","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib48","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1017\/S0022215116000554","article-title":"Non-melanoma skin cancer: United Kingdom national multidisciplinary guidelines","volume":"130","author":"Newlands","year":"2016","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.ejca.2019.06.003_bib49","first-page":"37","article-title":"A review of the global guidelines on surgical margins for nonmelanoma skin cancers","volume":"10","author":"Nahhas","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archderm.1987.01660270078019","article-title":"Surgical margins for basal cell carcinoma","volume":"123","author":"Wolf","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00128071-200203040-00003","article-title":"Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy","volume":"3","author":"Kuijpers","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib52","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/jdv.12689","article-title":"Narrow-margin excision is a safe, reliable treatment for well-defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan","volume":"29","author":"Ito","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cup.12401","article-title":"Study of shrinkage of cutaneous surgical specimens","volume":"42","author":"Blasco-Morente","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2019.06.003_bib54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1600-0560.2007.00943.x","article-title":"Shrinkage of cutaneous specimens: formalin or other factors involved?","volume":"35","author":"Kerns","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2019.06.003_bib55","first-page":"942","article-title":"S1 guideline: microscopically controlled surgery (MCS)","volume":"13","author":"L\u00f6ser","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2019.06.003_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/DSS.0000000000000296","article-title":"Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods","volume":"41","author":"Kauvar","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib57","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","article-title":"Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up","volume":"50","author":"van Loo","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.06.003_bib58","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bjps.2015.03.012","article-title":"Reconstructive outcomes of Mohs surgery compared with conventional excision: a 13-month prospective study","volume":"68","author":"Wain","year":"2015","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","article-title":"AAD\/ACMS\/ASDSA\/ASMS appropriate use criteria for Mohs micrographic surgery: a report of the American ACADEMY of Dermatology, American college of Mohs surgery, American society for dermatologic surgery association, and the American society for Mohs surgery","volume":"67","author":"Connolly","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib60","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/ijd.13326","article-title":"Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study","volume":"55","author":"Sin","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib61","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/bjd.14308","article-title":"Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread","volume":"174","author":"Hoorens","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/DSS.0000000000000394","article-title":"Long-term follow-up of positive surgical margins in basal cell carcinoma of the face","volume":"41","author":"Bozan","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib63","first-page":"145","article-title":"Basal cell carcinoma incompletely excised: a case-control study on recurrence","volume":"151","author":"Borghi","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bjps.2015.12.024","article-title":"Basal cell carcinomata: risk factors for incomplete excision and results of re-excision","volume":"69","author":"Masud","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib65","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ad.2011.03.020","article-title":"Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins","volume":"102","author":"Angulo","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ejca.2019.06.003_bib66","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2133.2004.06135.x","article-title":"Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions","volume":"151","author":"Boulinguez","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib67","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib68","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jid.2016.03.043","article-title":"Three-year follow-up results of photodynamic therapy vs. Imiquimod vs. Fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial","volume":"136","author":"Roozeboom","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jid.2017.09.033","article-title":"Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma","volume":"138","author":"Jansen","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaad.2015.03.048","article-title":"Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU)","volume":"73","author":"Roozeboom","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib71","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib72","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jid.2016.10.019","article-title":"Surgery versus imiquimod for nodular and superficial basal cell carcinoma (SINS) study group. Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial","volume":"137","author":"Williams","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib73","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2147\/OTT.S130371","article-title":"Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment","volume":"10","author":"Shi","year":"2017","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.ejca.2019.06.003_bib74","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2013.12.037","article-title":"Topical pharmacotherapy for skin cancer: part II. Clinical applications","volume":"70","author":"Micali","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib75","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1524-4725.1991.tb03425.x","article-title":"Recurrence rates of treated basal cell carcinomas: Part 2: curettage-electrodessication","volume":"17","author":"Silverman","year":"1991","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2006.07.007","article-title":"Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation","volume":"56","author":"Rodriguez-Vigil","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib77","first-page":"566","article-title":"Evidence-based review of use of cryosurgery in treatment of BCC","volume":"29","author":"Kokoszka","year":"2003","journal-title":"Derm Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib78","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial","volume":"18","author":"Basset-S\u00e9guin","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib79","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/DSS.0000000000001106","article-title":"Pulsed CO2 laser ablation of superficial basal cell of limbs and trunk: a comparative randomized clinical trial with cryotherapy and surgical ablation","volume":"43","author":"Zane","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib80","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaad.2015.12.008","article-title":"Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status","volume":"74","author":"Haedersdal","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/14764172.2017.1349321","article-title":"The use of lasers in the treatment of skin cancer: a review","volume":"19","author":"Mirza","year":"2017","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.ejca.2019.06.003_bib82","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jdv.13453","article-title":"Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"30","author":"Choi","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib83","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/jdv.14989","article-title":"Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's Disease: a randomised intra-patient comparison between a continuous and a fractional ablative CO2 laser mode","volume":"32","author":"Genouw","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib84","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/bjd.16838","article-title":"Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis","volume":"179","author":"Collier","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib85","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1468-3083.2008.02803.x","article-title":"A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8\u201320 mm), with a 12-month follow-up","volume":"22","author":"Szeimies","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib86","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five year follow up of a randomized prospective trial of topical methyl aminolevulinate-photodynamic therapy versus surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib87","first-page":"309","article-title":"A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy","volume":"179","author":"Morton","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib88","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1684\/ejd.2015.2570","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy","volume":"25","author":"Morton","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib89","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-1448","article-title":"Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial","volume":"92","author":"de Vijlder","year":"2012","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib90","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2013.02.014","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib91","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1365-2133.2012.10878.x","article-title":"High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study","volume":"166","author":"Christensen","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib92","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.clon.2009.03.004","article-title":"Efficacy of photodynamic therapy as a treatment for Gorlin Syndrome-related basal cell carcinomas","volume":"21","author":"Loncaster","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/lsm.20606","article-title":"Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma","volume":"40","author":"Smucler","year":"2008","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ejca.2019.06.003_bib94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-0960.2006.00222.x","article-title":"An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma","volume":"47","author":"Wu","year":"2006","journal-title":"Australas J Dermatol"},{"issue":"1 Suppl 1","key":"10.1016\/j.ejca.2019.06.003_bib95","first-page":"s7","article-title":"A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma","volume":"7","author":"Tillman","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib96","doi-asserted-by":"crossref","first-page":"25912","DOI":"10.3390\/ijms161025912","article-title":"Combined treatments with photodynamic therapy for non-melanoma skin cancer","volume":"16","author":"Lucena","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2019.06.003_bib97","doi-asserted-by":"crossref","first-page":"PI5","DOI":"10.12659\/MSM.882449","article-title":"The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma","volume":"18","author":"Osiecka","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejca.2019.06.003_bib98","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1468-3083.2011.04177.x","article-title":"A pilot study of clinical efficacy of imiquimod and cryotherapy for the treatment of basal cell carcinoma with incomplete response to imiquimod","volume":"26","author":"Messeguer","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2340\/00015555-1609","article-title":"Immunocryosurgery for non-superficial basal cell carcinoma: a prohspective, open-label phase III study for tumours <\/= 2 cm in diameter","volume":"94","author":"Gaitanis","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib100","first-page":"1462","article-title":"5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma","volume":"30","author":"Torres","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib101","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1524-4725.2009.01464.x","article-title":"Letter: imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study","volume":"36","author":"Moehrle","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib102","first-page":"461","article-title":"Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases","volume":"5","author":"Thissen","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib103","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1007\/s00405-016-4039-9","article-title":"Aggressive basal cell carcinoma of the head and neck: challenges in surgical management","volume":"273","author":"Lohuis","year":"2016","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.ejca.2019.06.003_bib104","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaad.2018.07.004","article-title":"Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: a systematic review and meta-analysis","volume":"79","author":"Xie","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib105","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.06.003_bib106","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejca.2017.08.022","article-title":"Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial","volume":"86","author":"Basset-S\u00e9guin","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.06.003_bib107","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2016.02.1226","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"75","author":"Dummer","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib108","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jdv.14542","article-title":"Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study","volume":"32","author":"Lear","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib109","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaad.2014.05.020","article-title":"An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma","volume":"71","author":"Ally","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaad.2016.02.1235","article-title":"Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC)","volume":"75","author":"Kwon","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib111","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamadermatol.2015.0326","article-title":"Concurrent vismodegib and radiotherapy for recurrent, advanced basal cell carcinoma","volume":"151","author":"Pollom","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib112","first-page":"1642","article-title":"Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management","volume":"34","author":"Geist","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib113","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12885-017-3286-5","article-title":"Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study","volume":"17","author":"Sekulic","year":"2017","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejca.2019.06.003_bib114","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1634\/theoncologist.2016-0186","article-title":"Characterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinoma","volume":"21","author":"Lacouture","year":"2016","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(17)30072-4","article-title":"Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial","volume":"18","author":"Dr\u00e9no","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib116","article-title":"Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience","author":"Woltsche","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib117","first-page":"77","article-title":"Treatments of advanced basal cell carcinoma: a review of the literature","volume":"151","author":"Peris","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.ejca.2019.06.003_bib118","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/bjd.14642","article-title":"Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases","volume":"175","author":"Borradori","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib119","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40425-016-0176-3","article-title":"Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810","volume":"4","author":"Falchook","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2019.06.003_bib120","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jaad.2018.08.017","article-title":"Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study","volume":"80","author":"Chang","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib121","first-page":"368","article-title":"[Radiotherapy of upper lip basalioma]","volume":"25","author":"Ehring","year":"1974","journal-title":"Hautarzt"},{"key":"10.1016\/j.ejca.2019.06.003_bib122","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1524-4725.1997.tb00454.x","article-title":"Radiation therapy in skin cancer. A historical perspective and current applications","volume":"23","author":"Halpern","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib123","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/M18-0678","article-title":"Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis","volume":"169","author":"Drucker","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2019.06.003_bib124","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","article-title":"GEC-ESTRO ACROP recommendations in skin brachytherapy","volume":"126","author":"Guinot","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5114\/jcb.2015.56465","article-title":"Brachytherapy in non melanoma skin cancer of eyelid: a systematic review","volume":"7","author":"Frakulli","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ejca.2019.06.003_bib126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/lary.25498","article-title":"Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas","volume":"126","author":"Bussu","year":"2016","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.ejca.2019.06.003_bib127","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5301\/tj.5000614","article-title":"Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review","volume":"103","author":"Tagliaferri","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.ejca.2019.06.003_bib128","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2016.10.008","article-title":"GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - improvement by cross sectional imaging based treatment planning and stepping source technology","volume":"122","author":"Kov\u00e1cs","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib129","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ejca.2013.03.010","article-title":"Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis","volume":"49","author":"Flohil","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.06.003_bib130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jdv.14587","article-title":"Risks of different skin tumor combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009","volume":"32","author":"van der Leest","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.ejca.2019.06.003_bib131","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/bjd.16900","article-title":"Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study","volume":"180","author":"van Egmond","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib132","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bjps.2017.04.006","article-title":"Risk factors for recurrence of facial basal cell carcinoma after surgical excision: a follow-up analysis","volume":"70","author":"Armstrong","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ejca.2019.06.003_bib133","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2133.2011.10488.x","article-title":"Cumulative risks and rates of subsequent basal cell carcinomas in The Netherlands","volume":"165","author":"Flohil","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib134","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamadermatol.2014.3307","article-title":"Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma","volume":"151","author":"Wehner","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10689-018-0073-7","article-title":"Mutations in the SUFU and PTCH1 genes cause different cutaneous cancer predisposition syndromes: similar but not the same","volume":"17","author":"Huq","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejca.2019.06.003_bib136","series-title":"GeneReviews\u00ae [internet]. Seattle (WA): University of Washington, Seattle; 1993-2019","article-title":"Nevoid basal cell carcinoma syndrome","author":"Evans","year":"2002"},{"key":"10.1016\/j.ejca.2019.06.003_bib137","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S1470-2045(16)30566-6","article-title":"Inhibition of the hedgehog pathway in patients with basal cell carcinoma syndrome: final results from the multicenter randomized double-blind placebo-controlled phase 2 trial","volume":"17","author":"Tang","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib138","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000444792","article-title":"Nevoid basal cell carcinoma syndrome: report from the Zurich nevoid basal cell carcinoma syndrome cohort","volume":"232","author":"Rehefeldt-Erne","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2019.06.003_bib139","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2014.58.2569","article-title":"Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations","volume":"32","author":"Smith","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.06.003_bib140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4161\/derm.24156","article-title":"The relevance of the Vitamin D endocrine system (VDES) for tumorigenesis: prevention and treatment on non melanoma skin cancer (NMSC). Present concepts and future perspectives","volume":"5","author":"Reichrath","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.ejca.2019.06.003_bib141","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent non melanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib142","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/1097-0142(20010715)92:2<354::AID-CNCR1330>3.0.CO;2-F","article-title":"Cutaneous basal cell carcinoma: distinct host factors associated with the development of tumors of the trunk and on the head and neck","volume":"92","author":"Ramachandran","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.06.003_bib143","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jaad.2015.08.073","article-title":"Familial skin cancer syndromes: increased risk of nonmelanotic skin cancers and extracutaneous tumours","volume":"74","author":"Jaju","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2019.06.003_bib144","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archdermatol.2010.247","article-title":"High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome","volume":"146","author":"Tang","year":"2010","journal-title":"Arch Dermatol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919303624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919303624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:25:04Z","timestamp":1760732704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919303624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":144,"alternative-id":["S0959804919303624"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.06.003","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and treatment of basal cell carcinoma: European consensus\u2013based interdisciplinary guidelines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}